Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Effectiveness of taxane- or anthracylin-based compared to taxane- and anthracyline-free 1st-line treatments in metastatic breast cancer patients in German oncology outpatient centres. Data from the clinical TMK Registry.

Marschner, N., Tesch, H., Dörfel, S., Meyer, D., Petersen, V., Jänicke, M., 2012.

Onkologie 35 (suppl 6)(P223), 68. doi:10.1159/000170919

Abstract

Download

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Onkologie
TMK
2012
Umsetzung von Leitlinien in der klinischen Praxis. Was können wir aus Klinischen Tumorregistern lernen?

Marschner, N., Kopfmann, S., 2012.

FORUM 27, 465–468.

Indikation: Other, Sonstige / Veranstaltung: - / Journal: Forum
Registerübergreifend
2012
Bendamustine-Rituximab (BR) Replaces R-CHOP As “Standard of Care” in the Treatment of Indolent Non-Hodgkin Lymphoma in German Hematology Outpatient Centres.

Knauf, W.U., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2012.

Blood 120(21), 3666.

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
TLN
2012
Bendamustine Replaces Chlorambucil As “Standard of Care” in the Treatment of Elderly Patients with Chronic Lymphocytic Leukemia in German Hematology Outpatient Centres.

Knauf, W.U., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2012.

Blood 120(21), 4605.

Abstract

Download

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
TLN
2012
Changes in German oncology outpatient centres of indolent non-Hodgkin lymphoma and chronic lymphocytic leukaemia in German haematology outpatient centres: Data from the clinical TLN Registry.

Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2012.

Onkologie 35 (suppl 6)(P724), 217. doi:10.1159/000178474

Abstract

Download

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: DGHO / Journal: Onkologie
TLN
2012
Register in der onkologischen Versorgungsforschung.

Klinkhammer-Schalke, M., Marschner, N., Hofstädter, F., 2012.

Der Onkologe 18, 142–150. doi:10.1007/s00761-011-2197-3

Abstract

Indikation: Other, Sonstige / Veranstaltung: - / Journal: Der Onkologe
Registerübergreifend
2012
Is there a difference in demography and clinical characteristics in patients treated with and without bevacizumab?

Hartmann, H., Müller, J., Marschner, N., 2012.

J Clin Oncol 30, 3317–3318. doi:10.1200/JCO.2012.43.3409

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: Journal of Clinical Oncology
Indikationsübergreifend
2012
Erneute Anti-HER2-Therapie mit Herceptin® beim ersten Rezidiv des HER2-positiven Mammakarzinoms-1. Interimsanalyse der nichtinterventionellen Studie (NIS) ML21589.

Hanker, L., Prange-Krex, G., Janssen, J., Reichert, D., Schröder, J., Förster, F., Schnohr, S., Hitschold, T., Indorf, M., Kaufmann, M., 2012.

Senologie 9(02). doi:10.1055/s-0032-1313426

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: Senologie Kongress / Journal: -
Herceptin-NIS
2012
Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM.

Hadji, P., Kieback, D.G., Tams, J., Hasenburg, A., Ziller, M., 2012.

Ann Oncol 23, 2566–2572. doi:10.1093/annonc/mds055.

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Annals of Oncology
TEAM
2012
Effects of exemestane and tamoxifen on hormone levels within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German substudy.

Hadji, P., Kauka, A., Bauer, T., Tams, J., Hasenburg, A., Kieback, D.G., 2012.

Climacteric 15, 460–466. doi:10.3109/13697137.2011.647839

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Climacteric
TEAM
2012